Mixed Schedule Study of Live Oral Rotavirus Vaccines and Trivalent P2-VP8 Subunit Rotavirus Vaccine
Condition:   Rotavirus Vaccine Interventions:   Biological: RV3-BB;   Biological: Trivalent P2-VP8;   Biological: Rotarix;   Biological: RV3-BB birth dose;   Biological: Trivalent P2-VP8 Booster dose Sponsors:   PATH;   SK Bioscience Co., Ltd.;   Murdoch Childrens Research Institute;   Children's Hospital Medical Center, Cincinnati;   Bill and Melinda Gates Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 14, 2020 Category: Research Source Type: clinical trials

Immunogenicity and Safety of Rotavirus RV3 Vaccine (Bio Farma) in Neonates
Condition:   Rotavirus Gastroenteritis Interventions:   Biological: Rotavirus RV3 Vaccine (Bio Farma);   Other: Placebo Sponsor:   PT Bio Farma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2019 Category: Research Source Type: clinical trials